The new law in Louisiana reclassifies mifepristone and misoprostol as controlled substances, sparking concerns among doctors about potential risks to patient health and access.
Doctors are worried that this law could restrict access to necessary medical treatments, especially in emergencies, due to the reclassification of these widely used medications.
Sarah Zagorski from Louisiana Right to Life asserts that the state has provided sufficient guidance to ensure these drugs can still be utilized in necessary medical situations.
The amendment to the bill, added late in the legislative process, has drawn significant backlash from the medical community who argue that the drugs are safe and essential.
[
Collection
]
[
|
...
]